Trigger Point Injection for Myofascial Pain Syndrome in the Low Back: A Randomized Controlled Trial

PHASE4RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

December 28, 2020

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2022

Conditions
Low Back PainMyofascial Pain Syndrome Lower Back
Interventions
DRUG

Treatment of Myofascial Pain Syndrome in the low back. This intervention will be based on outcomes of the medications listed below.

We are testing which of the three arms is superior for the treatment of Myofascial Pain Syndrome of the Low Back. Pain will be measured using a 10 cm visual analogue scale (VAS) at baseline and 30-minutes after treatment.

DRUG

Evaluation of functional ability using a patient centered functional score known as the Modified Oswestry Disability Index (MODI). The intervention will be based on outcomes of medications below.

Evaluation of functional ability using a patient centered functional score known as the MODI. The MODI will be scored at baseline and 30-minutes after treatment.

DRUG

Following up with participants 60-72 hours after treatment in the Emergency Department. This intervention will be based on outcomes of the medications listed below.

60-72 after treatment in the Emergency Department, a member of the study team will follow up with participants to repeat a measurement of pain and functional ability on VAS and MODI respectively. This will be compared to baseline measurements.

Trial Locations (1)

98431

RECRUITING

Department of Emergency Medicine, Madigan Army Medical Center, Tacoma

All Listed Sponsors
lead

Madigan Army Medical Center

FED